Literature DB >> 26050259

Carbohydrate-binding activities of coagulation factors fibrinogen and fibrin.

Kimie Date1, Mami Ohyama, Haruko Ogawa.   

Abstract

The coagulation factors fibrinogen and fibrin play important roles in the final stage of the blood coagulation cascade. It has not been revealed whether fibrinogen has lectin activity or not. Here we demonstrate that fibrinogen and fibrin have carbohydrate-specific binding activities that inhibit fibrin clot formation. A solid-phase binding study using sugar-biotinyl polymer probes revealed that fibrinogen has the highest affinity to mannose (Man) in both the presence and absence of 5 mM Ca(2+). Fibrin, which is proteolytically produced from fibrinogen by thrombin, binds to the same sugar residues as fibrinogen in the presence of 5 mM Ca(2+), while it markedly binds to N-acetylneuraminic acid in the absence of Ca(2+). Thrombin-induced fibrin polymerization was monitored by turbidity at 350 nm. In the presence of Ca(2+), Man and sugars having N-acetyl groups were found to inhibit the increase in turbidity, but only Man inhibited it in the absence of Ca(2+). Scanning electron microscopy observation of fibrin clots formed in the presence of various sugars showed that fibrin fibers formed in the presence of Man and N-acetyl group sugars were thinner and more branched. In contrast, thrombin has neither carbohydrate-binding activity nor is affected by sugars. These results suggest that carbohydrates and glycoconjugates may regulate fibrin clot formation in vivo.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26050259     DOI: 10.1007/s10719-015-9603-9

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  24 in total

1.  Interaction of fibrin(ogen) with fibronectin: further characterization and localization of the fibronectin-binding site.

Authors:  Evgeny Makogonenko; Galina Tsurupa; Kenneth Ingham; Leonid Medved
Journal:  Biochemistry       Date:  2002-06-25       Impact factor: 3.162

2.  Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains.

Authors:  Kevin R Siebenlist; Michael W Mosesson; Irene Hernandez; Leslie A Bush; Enrico Di Cera; John R Shainoff; James P Di Orio; Laurie Stojanovic
Journal:  Blood       Date:  2005-07-07       Impact factor: 22.113

Review 3.  The anticoagulant and antithrombotic mechanisms of heparin.

Authors:  Elaine Gray; John Hogwood; Barbara Mulloy
Journal:  Handb Exp Pharmacol       Date:  2012

4.  Acceleration of fibrin polymerization by calcium ions.

Authors:  M H Boyer; J R Shainoff; O D Ratnoff
Journal:  Blood       Date:  1972-03       Impact factor: 22.113

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  [Participation of sialic acid residue in the fibrinogen-fibrin conversion by thrombin].

Authors:  S Akihama; Y Matsuda; T Fukase; A Yamanaka; M Okude
Journal:  Yakugaku Zasshi       Date:  1995-07       Impact factor: 0.302

7.  Sialic acid in fibrinogen: effects of sialic acid on fibrinogen-fibrin conversion by thrombin and properties of asialofibrin clot.

Authors:  M Okude; A Yamanaka; Y Morimoto; S Akihama
Journal:  Biol Pharm Bull       Date:  1993-05       Impact factor: 2.233

8.  Glycaemic control improves fibrin network characteristics in type 2 diabetes - a purified fibrinogen model.

Authors:  Marlien Pieters; Namukolo Covic; Francois H van der Westhuizen; Chandrasekaran Nagaswami; Yelena Baras; Du Toit Loots; Johann C Jerling; Dale Elgar; Kathryn S Edmondson; Danie G van Zyl; Paul Rheeder; John W Weisel
Journal:  Thromb Haemost       Date:  2008-04       Impact factor: 5.249

9.  Glycosylation of human fibrinogen and fibrin in vitro. Its consequences on the properties of fibrin(ogen).

Authors:  M Mirshahi; J Soria; C Soria; O Bertrand; M Mirshahi; A Basdevant
Journal:  Thromb Res       Date:  1987-11-01       Impact factor: 3.944

10.  Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The EURODIAB Prospective Complications Study (PCS).

Authors:  S S Soedamah-Muthu; N Chaturvedi; J C Pickup; J H Fuller
Journal:  Diabetologia       Date:  2008-01-09       Impact factor: 10.122

View more
  2 in total

1.  Fibrinogen and C-reactive protein score is a prognostic index for patients with hepatocellular carcinoma undergoing curative resection: a prognostic nomogram study.

Authors:  Wei Gan; Yong Yi; Yipeng Fu; Jinlong Huang; Zhufeng Lu; Chuyu Jing; Jia Fan; Jian Zhou; Shuangjian Qiu
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

2.  Effects of Post-Translational Modifications of Fibrinogen on Clot Formation, Clot Structure, and Fibrinolysis: A Systematic Review.

Authors:  Judith J de Vries; Charlotte J M Snoek; Dingeman C Rijken; Moniek P M de Maat
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-01-09       Impact factor: 8.311

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.